News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
195,175 Results
Type
Article (14030)
Company Profile (23)
Press Release (181122)
Multimedia
Podcasts (10)
Webinars (5)
Section
Business (54428)
Career Advice (615)
Deals (10658)
Drug Delivery (30)
Drug Development (29565)
Employer Resources (70)
FDA (5153)
Job Trends (4232)
News (100937)
Policy (8866)
Tag
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1084)
Academic (1)
Accelerated approval (1)
Adcomms (6)
Allergies (32)
Alliances (15080)
ALS (37)
Alzheimer's disease (445)
Antibody-drug conjugate (ADC) (22)
Approvals (5172)
Artificial intelligence (63)
Autoimmune disease (8)
Automation (3)
Bankruptcy (74)
Best Places to Work (3371)
BIOSECURE Act (6)
Biosimilars (34)
Biotechnology (11)
Bladder cancer (22)
Brain cancer (9)
Breast cancer (82)
Cancer (599)
Cardiovascular disease (63)
Career advice (516)
Career pathing (13)
CAR-T (45)
Cell therapy (116)
Cervical cancer (9)
Clinical research (25172)
Collaboration (187)
Compensation (27)
Complete response letters (1)
COVID-19 (1091)
CRISPR (8)
C-suite (61)
Cystic fibrosis (21)
Data (752)
Denatured (7)
Depression (11)
Diabetes (101)
Diagnostics (1780)
Digital health (4)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (38)
Drug pricing (39)
Drug shortages (16)
Duchenne muscular dystrophy (31)
Earnings (16813)
Editorial (16)
Employer branding (5)
Employer resources (64)
Events (23300)
Executive appointments (213)
FDA (5507)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (208)
Gene editing (17)
Generative AI (6)
Gene therapy (85)
GLP-1 (273)
Government (1210)
Grass and pollen (2)
Guidances (12)
Healthcare (5666)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (31)
Indications (7)
Infectious disease (1137)
Inflammatory bowel disease (53)
Inflation Reduction Act (4)
Influenza (15)
Intellectual property (18)
Interviews (104)
IPO (3946)
IRA (19)
Job creations (991)
Job search strategy (454)
Kidney cancer (2)
Labor market (7)
Layoffs (83)
Leadership (7)
Legal (1945)
Liver cancer (23)
Lung cancer (66)
Lymphoma (42)
Machine learning (2)
Management (23)
Manufacturing (72)
MASH (33)
Medical device (3375)
Medtech (3377)
Mergers & acquisitions (6875)
Metabolic disorders (226)
Multiple sclerosis (38)
NASH (15)
Neurodegenerative disease (21)
Neuropsychiatric disorders (5)
Neuroscience (631)
NextGen: Class of 2025 (2038)
Non-profit (1640)
Northern California (536)
Now hiring (1)
Obesity (103)
Opinion (48)
Ovarian cancer (18)
Pain (32)
Pancreatic cancer (21)
Parkinson's disease (55)
Partnered (7)
Patents (32)
Patient recruitment (35)
Peanut (17)
People (19147)
Pharmaceutical (11)
Pharmacy benefit managers (9)
Phase I (5642)
Phase II (10740)
Phase III (10199)
Pipeline (311)
Policy (55)
Postmarket research (1294)
Preclinical (2027)
Press Release (30)
Prostate cancer (37)
Psychedelics (9)
Radiopharmaceuticals (72)
Rare diseases (107)
Real estate (1498)
Recruiting (23)
Regulatory (6360)
Reports (18)
Research institute (908)
Resumes & cover letters (82)
Rett syndrome (1)
RSV (19)
Schizophrenia (25)
Series A (50)
Series B (31)
Service/supplier (2)
Sickle cell disease (12)
Southern California (512)
Special edition (2)
Spinal muscular atrophy (63)
Sponsored (5)
Startups (1251)
Stomach cancer (4)
Supply chain (15)
Tariffs (7)
The Weekly (3)
United States (5130)
Vaccines (283)
Venture capitalists (8)
Weight loss (69)
Women's health (15)
Worklife (6)
Date
Today (38)
Last 7 days (149)
Last 30 days (618)
Last 365 days (8650)
2025 (2595)
2024 (9163)
2023 (10541)
2022 (15317)
2021 (16568)
2020 (15760)
2019 (14458)
2018 (11161)
2017 (10525)
2016 (10136)
2015 (12215)
2014 (8429)
2013 (6478)
2012 (6931)
2011 (7213)
2010 (6290)
Location
Africa (263)
Alabama (9)
Alaska (4)
Arizona (42)
Arkansas (2)
Asia (13065)
Australia (2465)
California (1251)
Canada (394)
China (146)
Colorado (53)
Connecticut (51)
Delaware (37)
Europe (44059)
Florida (171)
Georgia (71)
Idaho (14)
Illinois (151)
India (11)
Indiana (87)
Iowa (3)
Japan (67)
Kansas (30)
Kentucky (7)
Louisiana (6)
Maine (11)
Maryland (235)
Massachusetts (916)
Michigan (38)
Minnesota (85)
Missouri (19)
Montana (6)
Nebraska (6)
Nevada (17)
New Hampshire (10)
New Jersey (461)
New Mexico (7)
New York (490)
North Carolina (215)
Northern California (536)
Ohio (40)
Oklahoma (4)
Oregon (5)
Pennsylvania (328)
Puerto Rico (3)
Rhode Island (4)
South America (395)
South Carolina (8)
Southern California (512)
Tennessee (17)
Texas (152)
Utah (23)
Virginia (39)
Washington D.C. (7)
Washington State (166)
Wisconsin (10)
195,175 Results for "celltech group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
NK CellTech Announces FDA Clearance for Clinical Trial of NK010
On January 17, 2024 , NK CellTech Co., Ltd. (NK CellTech), a leading biotech company focused on the development of NK cellular therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of NK010, the non-genetically modified natural killer cells.
January 22, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 3, 2025
·
3 min read
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
Press Releases
Genflow Biosciences PLC Launches New Development Program
April 10, 2025
·
2 min read
Press Releases
Genflow Biosciences PLC Announces Launch of AI-Powered Partnership
April 14, 2025
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
March 17, 2025
·
2 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
March 6, 2025
·
1 min read
Press Releases
ICON plc Schedules First Quarter 2025 Earnings Conference Call
March 31, 2025
·
2 min read
Press Releases
ICON plc to Present at Upcoming Investor Conferences
March 5, 2025
·
2 min read
1 of 19,518
Next
